TrueMark Investments »

Abcellera Biologics shares owned by TrueMark Investments

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by TrueMark Investments from 13F filings

Historical chart of TrueMark Investments investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by TrueMark Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by TrueMark Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $498k 110k 4.53
2023-12-31 $553k 97k 5.71

More positions owned by TrueMark Investments

NVIDIA Corporation (NVDA)
Citigroup Com New (C)
Broadcom (AVGO)
Blue Owl Capital Com Cl A (OWL)
Crowdstrike Hldgs Cl A (CRWD)
Qualcomm (QCOM)
Samsara Com Cl A (IOT)
Verizon Communications (VZ)
Nextera Energy (NEE)
American Electric Power Company (AEP)
British Amern Tob Sponsored Adr (BTI)
Advanced Micro Devices (AMD)
Exxon Mobil Corporation (XOM)
Oracle Corporation (ORCL)
Chevron Corporation (CVX)

View all positions for TrueMark Investments

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors
Two Sigma Advisers
Norges Bank Investment Management

View all funds holding Abcellera Biologics